Open Access
Volume 7, Number 4, December 2017
Article Number 21
Number of page(s) 3
Published online 13 November 2017
  1. Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, et al. Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res 2006; 66: 7216-24. [CrossRef] [Google Scholar]
  2. Cancer Research UK. Worldwide Cancer Statistics. 2016. Accessed 18/09/2016. [Google Scholar]
  3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. [CrossRef] [PubMed] [Google Scholar]
  4. Callahan, C,Brintzenhofeszoc K. Financial Quality of Life for Patients With Cancer: An Exploratory Study. J Psychosoc Oncol. 2015, 33: 377-94. [CrossRef] [Google Scholar]
  5. Heydarnejad MS, Hassanpour DA, Solati DK. Factors affecting quality of life in cancer patients undergoing chemotherapy. Afr Health Sci. 2011, 11: 266-70. [PubMed] [Google Scholar]
  6. Khan, N, Mukhtar H. Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev. 2010, 29: 435-45. [CrossRef] [PubMed] [Google Scholar]
  7. Chiang AC, Massagué J. Molecular Basis of Metastasis. N Engl J Med. 2008, 359: 2814-23. [CrossRef] [PubMed] [Google Scholar]
  8. Steeg PS. Targeting metastasis. Nature Reviews Cancer. 2016, 16:201-201. [CrossRef] [PubMed] [Google Scholar]
  9. Lou XL, Sun J, Gong SQ, Yu XF, Gong R, Deng H. Interaction between circulating cancer cells and platelets: clinical implication. Chin J Cancer Res. 2015, 27: 450-60. [PubMed] [Google Scholar]
  10. Varki, A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007, 110: 1723-9. [CrossRef] [PubMed] [Google Scholar]
  11. Sharma, D,Brummel-Ziedins KE, Bouchard BA, Holmes CE. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol. 2014, 229: 1005-15. [CrossRef] [PubMed] [Google Scholar]
  12. Li, N. Platelets in cancer metastasis: To help the “villain” to do evil. Int J Cancer. 2016, 138: 2078-87. [CrossRef] [PubMed] [Google Scholar]
  13. Labelle, M,Begum S, Hynes RO. Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A. 2014, 111: E3053-61. [CrossRef] [PubMed] [Google Scholar]
  14. Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 2009, 135: 505-12. [CrossRef] [PubMed] [Google Scholar]
  15. Rachagani, S,Torres MP, Moniaux N, Batra SK. Current status of mucins in the diagnosis and therapy of cancer. Biofactors. 2009, 35: 509-27. [CrossRef] [PubMed] [Google Scholar]
  16. Wang RQ, Fang DC. Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features. J Clin Pathol. 2003, 56: 378-84. [CrossRef] [PubMed] [Google Scholar]
  17. Duncan TJ, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. World J Surg Oncol. 2007, 5: 31. [CrossRef] [PubMed] [Google Scholar]
  18. Choi JS, Lee KMA, Lee HE, Lee HS, Kim WH. Mucinous gastric carcinomas. Cancer. 2009, 115: 3581-90. [CrossRef] [PubMed] [Google Scholar]
  19. Borsig, L,Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A. 2001, 98: 3352-7. [CrossRef] [PubMed] [Google Scholar]
  20. Varki, A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007, 110: 1723-9. [CrossRef] [PubMed] [Google Scholar]
  21. Fukuda, M. Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 1996; 56: 2237-44. [Google Scholar]
  22. Varki, N.M., Varki, A. Semin. Thromb. Hemostasis, in press. 2002. [Google Scholar]
  23. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996, 88: 3259-87. [Google Scholar]
  24. Varki, A. Selectin ligands. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:7390-7390. [CrossRef] [PubMed] [Google Scholar]
  25. Evangelista, V,Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A. et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood. 1999, 93:876-876. [Google Scholar]
  26. Hidari KI, Weyrich AS, Zimmerman GA, McEver RP. Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J. Biol. Chem. 1997; 272: 28750-6. [CrossRef] [PubMed] [Google Scholar]
  27. Merten, M, Thiagarajan P. Role for sulfatides in platelet aggregation. Circulation. 2001, 104: 2955-60. [CrossRef] [PubMed] [Google Scholar]
  28. Kim YJ, Borsig L, Varki NM, Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A. 1998,95: 9325-30. [CrossRef] [PubMed] [Google Scholar]